medroxyprogesterone acetate has been researched along with Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bunce, CM; Constantinou, JK; Drayson, MT; Hayden, RE; Khanim, FL; Koczula, KM; Michell, RH; Southam, AD; Viant, MR | 1 |
| Lanari, C; Molinolo, AA; Pazos, P | 1 |
2 other study(ies) available for medroxyprogesterone acetate and Lymphoma
| Article | Year |
|---|---|
Drug Redeployment to Kill Leukemia and Lymphoma Cells by Disrupting SCD1-Mediated Synthesis of Monounsaturated Fatty Acids.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bezafibrate; Cell Line, Tumor; Fatty Acids, Monounsaturated; HL-60 Cells; Humans; K562 Cells; Leukemia; Lipid Metabolism; Lymphoma; Medroxyprogesterone Acetate; Prognosis; Stearoyl-CoA Desaturase | 2015 |
Protective role of medroxyprogesterone acetate on N-methyl-N-nitrosourea-induced lymphomas in BALB/c female mice.
Topics: Animals; Female; Immunohistochemistry; Incidence; Lymphoma; Medroxyprogesterone Acetate; Methylnitrosourea; Mice; Mice, Inbred BALB C | 2001 |